» Articles » PMID: 33321866

Ca Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer's Disease

Overview
Journal Cells
Publisher MDPI
Date 2020 Dec 16
PMID 33321866
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Ca homeostasis is essential for multiple neuronal functions and thus, Ca dyshomeostasis can lead to widespread impairment of cellular and synaptic signaling, subsequently contributing to dementia and Alzheimer's disease (AD). While numerous studies implicate Ca mishandling in AD, the cellular basis for loss of cognitive function remains under investigation. The process of synaptic degradation and degeneration in AD is slow, and constitutes a series of maladaptive processes each contributing to a further destabilization of the Ca homeostatic machinery. Ca homeostasis involves precise maintenance of cytosolic Ca levels, despite extracellular influx via multiple synaptic Ca channels, and intracellular release via organelles such as the endoplasmic reticulum (ER) via ryanodine receptor (RyRs) and IPR, lysosomes via transient receptor potential mucolipin channel (TRPML) and two pore channel (TPC), and mitochondria via the permeability transition pore (PTP). Furthermore, functioning of these organelles relies upon regulated inter-organelle Ca handling, with aberrant signaling resulting in synaptic dysfunction, protein mishandling, oxidative stress and defective bioenergetics, among other consequences consistent with AD. With few effective treatments currently available to mitigate AD, the past few years have seen a significant increase in the study of synaptic and cellular mechanisms as drivers of AD, including Ca dyshomeostasis. Here, we detail some key findings and discuss implications for future AD treatments.

Citing Articles

Neurosteroids Alter p-ERK Levels and Tau Distribution, Restraining the Effects of High Extracellular Calcium.

Konsta V, Paschou M, Koti N, Vlachou M, Livanos P, Xilouri M Int J Mol Sci. 2024; 25(21).

PMID: 39519194 PMC: 11546054. DOI: 10.3390/ijms252111637.


Autophagy-lysosomal-associated neuronal death in neurodegenerative disease.

Nixon R Acta Neuropathol. 2024; 148(1):42.

PMID: 39259382 PMC: 11418399. DOI: 10.1007/s00401-024-02799-7.


Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.

Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L Signal Transduct Target Ther. 2024; 9(1):211.

PMID: 39174535 PMC: 11344989. DOI: 10.1038/s41392-024-01911-3.


Calcium channel signalling at neuronal endoplasmic reticulum-plasma membrane junctions.

Maciag F, Chhikara A, Heine M Biochem Soc Trans. 2024; 52(4):1617-1629.

PMID: 38934485 PMC: 11668288. DOI: 10.1042/BST20230819.


Biomarker evidence of early vision and rod energy-linked pathophysiology benefits from very low dose DMSO in 5xFAD mice.

Berkowitz B, Paruchuri A, Stanek J, Abdul-Nabi M, Podolsky R, Bustos A Acta Neuropathol Commun. 2024; 12(1):85.

PMID: 38822433 PMC: 11140992. DOI: 10.1186/s40478-024-01799-8.


References
1.
Murchison D, McDermott A, LaSarge C, Peebles K, Bizon J, Griffith W . Enhanced calcium buffering in F344 rat cholinergic basal forebrain neurons is associated with age-related cognitive impairment. J Neurophysiol. 2009; 102(4):2194-207. PMC: 2775378. DOI: 10.1152/jn.00301.2009. View

2.
Gobbi P, Castaldo P, Minelli A, Salucci S, Magi S, Corcione E . Mitochondrial localization of Na+/Ca2+ exchangers NCX1-3 in neurons and astrocytes of adult rat brain in situ. Pharmacol Res. 2007; 56(6):556-65. DOI: 10.1016/j.phrs.2007.10.005. View

3.
Green K, Demuro A, Akbari Y, Hitt B, Smith I, Parker I . SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. J Cell Biol. 2008; 181(7):1107-16. PMC: 2442205. DOI: 10.1083/jcb.200706171. View

4.
Schon E, Area-Gomez E . Mitochondria-associated ER membranes in Alzheimer disease. Mol Cell Neurosci. 2012; 55:26-36. DOI: 10.1016/j.mcn.2012.07.011. View

5.
Volgyi K, Badics K, Sialana F, Gulyassy P, Udvari E, Kis V . Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease. Mol Neurobiol. 2018; 55(10):7839-7857. DOI: 10.1007/s12035-018-0955-6. View